Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats.
about
Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesStatin use is associated with a reduced risk of fibrosis progression in chronic hepatitis CSimvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosisFluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in ratsAtorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.Searching the place of pitavastatin in the current treatment of patients with dyslipidemia.Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.Antifibrotic effect of AT-1 blocker and statin in rats with hepatic fibrosis.Pitavastatin ameliorated the progression of steatohepatitis in ovariectomized mice fed a high fat and high cholesterol diet.Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
P2860
Q28081216-4CC79F32-6D9D-4758-9F91-4C69B63B7AEFQ34747195-532B4745-C737-4A94-BCFA-C38DBF717148Q35009517-06D63669-AB53-4E40-BE5B-1B6F0E68D1F0Q35107757-AD8D41F3-A244-4CAF-8DB9-E3BA2C4091C9Q36541169-E3444851-6D18-4446-969C-7655741D73F8Q37029796-91163F44-6B7F-4E07-ABF4-9D2BBED8B602Q38161516-C270F32E-7A56-44BE-9D47-B4DB7E8B2CF9Q38819131-A7D45EAA-07ED-40FF-BC35-FC723F990502Q40736144-7F43D68D-2E32-4C5C-9628-23F82CDA55ACQ43845439-69E21A72-1EAC-4BEA-8E44-606FC3FBBEBAQ50698691-747213B7-0144-49F9-BD71-059A7CF55013
P2860
Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Pitavastatin inhibits hepatic ...... ic steatohepatitis model rats.
@en
Pitavastatin inhibits hepatic ...... ic steatohepatitis model rats.
@nl
type
label
Pitavastatin inhibits hepatic ...... ic steatohepatitis model rats.
@en
Pitavastatin inhibits hepatic ...... ic steatohepatitis model rats.
@nl
prefLabel
Pitavastatin inhibits hepatic ...... ic steatohepatitis model rats.
@en
Pitavastatin inhibits hepatic ...... ic steatohepatitis model rats.
@nl
P2093
P2860
P1433
P1476
Pitavastatin inhibits hepatic ...... ic steatohepatitis model rats.
@en
P2093
Atsunori Kusakabe
Etsuko Iio
Kazuo Ikeda
Kentaro Matsuura
Noboru Shinkai
Satoru Takahashi
Shunsuke Nojiri
Takashi Joh
Tomokatsu Miyaki
P2860
P304
P356
10.1111/J.1872-034X.2010.00769.X
P577
2011-01-30T00:00:00Z